All Stories

  1. The Possible Impact of COVID-19 on Glycated Hemoglobin and Systolic Blood Pressure in Type 2 Diabetes and Obesity
  2. The Impact of a Nutritional Intervention on Glycemic Control and Cardiovascular Risk Markers in Type 2 Diabetes
  3. AGE AND BLOOD PRESSURE DEPENDENCY OF THREE DIFFERENT METHODS TO MEASURE PULSE WAVE VELOCITY
  4. EFFECT OF SEQUENTIAL NEPHRON BLOCKADE X DUAL RENIN-ANGIOTENSIN SYSTEM BLOCKADE + BISOPROLOL IN THE TREATMENT OF RESISTANT HYPERTENSION, A RANDOMIZED CONTROLLED TRIAL (RESHYPOT)
  5. Correlation between estimated pulse wave velocity values from two equations in healthy and under cardiovascular risk populations
  6. Effects of Mindful Eating in Patients with Obesity and Binge Eating Disorder
  7. Diretrizes Brasileiras de Medidas da Pressão Arterial Dentro e Fora do Consultório – 2023
  8. Nutritional Strategies for the Management of Type 2 Diabetes Mellitus: A Narrative Review
  9. Evaluation of Central Hemodynamics in the Diagnosis and Treatment of Hypertension
  10. Diretrizes Brasileiras de Medidas da Pressão Arterial Dentro e Fora do Consultório – 2023
  11. EXPRESSION OF MICRO-RNA 221 AND 223 IN ISCHEMIC STROKE DUE HYPERTENSIVE EMERGENCY
  12. ARTERIAL STIFFNESS IN NORMOTENSIVE PATIENTS WITH HYPOPARATHYROIDISM COMPARED TO CONTROLS
  13. SEQUENTIAL NEPHRON BLOCKADE VERSUS DUAL RENIN-ANGIOTENSIN SYSTEM BLOCKADE IN TRUE RESISTANT HYPERTENSIVE PATIENTS: A SYSTEMATIC REVIEW
  14. EVALUATION OF DEPENDENCE OF AGE AND PERIPHERAL BLOOD PRESSURE IN TWO PULSE WAVE VELOCITY ESTIMATION METHODS
  15. The Effect of Transcutaneous Electrical Nerve Stimulation in Peripheral and Central Hemodynamic Parameters on Resistant Hypertension: A Case Report
  16. The Role of Heart Rate Variability (HRV) in Different Hypertensive Syndromes
  17. Effect of Sequential Nephron Blockade versus Dual Renin-Angiotensin System Blockade Plus Bisoprolol in the Treatment of Resistant Hypertension, a Randomized Controlled Trial (Resistant Hypertension on Treatment - ResHypOT)
  18. Editorial: The importance of the central hemodynamic in the cardiovascular diseases development
  19. Inflammatory cytokines are associated to lower glomerular filtration rate in patients with hypertensive crisis
  20. Linear and non-linear analyses of autonomic modulation in uncontrolled and controlled elderly resistant hypertensives
  21. Alterations in pro- and anti-inflammatory mediators are involved in microvascular dysfunction in postmenopausal women with type 2 diabetes mellitus
  22. Smoking and Endothelial Dysfunction: An Integrated - Medical and Molecular Review
  23. CRISES HIPERTENSIVAS: MITOS, VERDADES E CONDUTAS
  24. HIPERTENSÃO E DIABETES: CONCEITOS ATUAIS NA TERAPÊUTICA
  25. Predictive Factors for Target Organ Injuries in Hypertensive Individuals
  26. RELATIONSHIP BETWEEN 24-HOURS URINARY SODIUM EXCRETION AND ARTERIAL STIFFNESS IN CONTROLLED HYPERTENSIVE AND RESISTANT HYPERTENSIVE INDIVIDUALS
  27. Diretrizes Brasileiras de Hipertensão Arterial – 2020
  28. Evidence of Nonadherence in Cases of Pseudoresistant Hypertension
  29. Implications for Clinical Practice from a Multicenter Survey of Heart Failure Management Centers
  30. QUAL O PAPEL DO BLOQUEIO SEQUENCIAL DO NÉFRON NA HIPERTENSÃO RESISTENTE?
  31. Avaliação do Seguimento de 1 Ano dos Pacientes Incluídos no Registro da Prática Clínica em Pacientes de Alto Risco Cardiovascular (REACT)
  32. Effectiveness of chlorthalidone/amiloride versus losartan in patients with stage I hypertension and diabetes mellitus: results from the PREVER-treatment randomized controlled trial
  33. Randomized Study Comparing Vildagliptin vs Glibenclamide on Glucose Variability and Endothelial Function in Patients with Type 2 Diabetes Mellitus and Hypertension
  34. Abstract P081: Expression Of Micro-rnas And Transfer Of Lipids To HDL In Vitro In Stroke Due To Hypertensive Emergency
  35. May Measurement Month 2018: an analysis of blood pressure screening results from Brazil
  36. Posicionamento Luso-Brasileiro de Emergências Hipertensivas – 2020
  37. Plasma levels of matrix metalloproteinase-9 are elevated in individuals with hypertensive crisis
  38. Posicionamento Brasileiro sobre Hipertensão Arterial Resistente – 2020
  39. Central Hemodynamic Parameters are Altered in Resistant Hypertensive Individuals
  40. CRISES HIPERTENSIVAS: DEFININDO A GRAVIDADE E O TRATAMENTO
  41. Effect of vildagliptin versus glibenclamide on endothelial function and arterial stiffness in patients with type 2 diabetes and hypertension: a randomized controlled trial
  42. Effectiveness of low-dose diuretics for blood pressure reduction to optimal values in prehypertension
  43. Controlled Versus Uncontrolled Resistant Hypertension: Are They in the Same Bag?
  44. Resistant Hypertension On Treatment (ResHypOT): sequential nephron blockade compared to dual blockade of the renin-angiotensin-aldosterone system plus bisoprolol in the treatment of resistant arterial hypertension – study protocol for a randomized cont...
  45. Prevalence of Physical Inactivity and its Effects on Blood Pressure and Metabolic Parameters in a Brazilian Urban Population
  46. Do thiazide diuretics reduce central systolic blood pressure in hypertension?
  47. Effects of acute blood pressure elevation on biochemical-metabolic parameters in individuals with hypertensive crisis
  48. I Luso-Brazilian Positioning on Central Arterial Pressure
  49. Endothelial Changes in Individuals with Prehypertension
  50. How to Investigate the Vascular Changes in Resistant Hypertension
  51. Spotlight on valsartan–sacubitril fixed-dose combination for heart failure: the evidence to date
  52. Angiotensin-converting enzyme insertion/deletion polymorphism, 24-h blood pressure profile and left ventricular hypertrophy in hypertensive individuals: a cross-sectional study
  53. DPP-4 Inhibitor Reduces Central Blood Pressure in a Diabetic and Hypertensive Patient
  54. PP.28.15
  55. Effect of transcutaneous electrical nerve stimulation on peripheral to central blood pressure ratio in healthy subjects
  56. Blockade of Renin Angiotensin System in Heart Failure Post-Myocardial Infarction: What is the Best Therapy?
  57. Prevalence of Metabolic Syndrome: Association with Risk Factors and Cardiovascular Complications in an Urban Population
  58. Is There an Association between Periodontitis and Hypertension?
  59. Nebivolol reduces central blood pressure in stage I hypertensive patients: experimental single cohort study
  60. Alogliptin after Acute Coronary Syndrome in Patients with Type 2 Diabetes
  61. Renin Angiotensin System Blockage Associates with Insertion/Deletion Polymorphism of Angiotensin-Converting Enzyme in Patients with Hypertensive Emergency
  62. Evidence-Based Therapy Prescription in High-Cardiovascular Risk Patients: The REACT Study
  63. Carotid intima-media thickness is associated with cognitive deficiency in hypertensive patients with elevated central systolic blood pressure
  64. Urinary albumin excretion regression in hypertensive individuals
  65. Hyperglycemia in patients with hypertensive crisis: Response to “Hypertensive crisis: Comparison between diabetics and non-diabetics”
  66. Fatores associados ao aumento no índice de incremento de pressão radial em indivíduos hipertensos
  67. Gene Variation in Resistant Hypertension: Multilocus Analysis of the Angiotensin 1-Converting Enzyme, Angiotensinogen, and Endothelial Nitric Oxide Synthase Genes
  68. Is There An Association Between Vitamin D and Hypertension?
  69. Prevention of hypertension in patients with pre-hypertension: protocol for the PREVER-prevention trial
  70. Hypertensive crisis: clinical–epidemiological profile
  71. Factors associated with impaired urinary albumin excretion in hypertensive individuals
  72. Prevalência e fatores de risco para hipertensão em uma população urbana brasileira
  73. ARTERIAL AND VENOUS ENDOTHELIAL DYSFUNCTION IN RESISTANT HYPERTENSIVE PATIENTS
  74. Coronary emergency and diabetes as manifestations of pheochromocytoma
  75. Ausência de descenso noturno se associa a acidente vascular cerebral e infarto do miocárdio
  76. Evaluation of the awareness, control and cost-effectiveness of hypertension treatment in a Brazilian city: populational study
  77. Factors associated to patients' noncompliance with hypertension treatment
  78. Dissecção aguda de aorta como apresentação de emergência hipertensiva
  79. Prevalência e fatores sociodemográficos em hipertensos de São José do Rio Preto - SP
  80. Disfunção cognitiva após cirurgia cardíaca
  81. H 023 α-ADDUCIN GENETIC VARIANTS AND RISK FACTORS IN SYSTEMIC HYPERTENSION
  82. H 031 THE PREVALENCE OF METABOLIC SYNDROME IN PATIENTS SUFFERING FROM HYPERTENSIVE CRISES
  83. H 024 POLYMORPHISMS OF THE ACE INSERTION/DELETION, M235T ANGIOTENSINOGEN AND ENOS GLU298ASP GENES IN REFRACTORY HYPERTENSION
  84. H 025 EVALUATION OF ENDOTHELIAL FUNCTION AND VASCULAR THICKNESS IN REFRACTORY HYPERTENSIVE PATIENTS
  85. H 026 CARDIOVASCULAR REMODELING (CONCENTRIC LEFT VENTRICLE HYPERTROPHY AND INCREASE IN THE INTIMA-MEDIA THICKNESS) IN REFRACTORY HYPERTENSION
  86. H 029 ACE GENETIC POLYMORPHISMS IN PATIENTS SUFFERING HYPERTENSIVE CRISES
  87. H 036 CARDIOVASCULAR RISK STRATIFICATION IN PATIENTS WITH REFRACTORY ARTERIAL HYPERTENSION
  88. Infarto agudo do miocárdio e dissecção aguda de aorta: um importante diagnóstico diferencial
  89. Perfil de crise hipertensiva: prevalência e apresentação clínica
  90. Adenoma de Conn: uma causa de hipertensão e hipocalemia